Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Arbutus Biopharma | ABUS | Nov 18, 2024 | 3.52 | -3.30 |
ARC Document Solutions | ARC | Nov 18, 2024 | 3.39 | 0.00 |
Arcadia Biosciences | RKDA | Nov 18, 2024 | 2.84 | -2.07 |
Arcadium Lithium | ALTM | Nov 18, 2024 | 5.20 | -0.38 |
ArcBest | ARCB | Nov 18, 2024 | 108.25 | -0.13 |
Arcellx | ACLX | Nov 18, 2024 | 88.22 | +0.44 |
Arcelor Mittal ADR | MT | Nov 18, 2024 | 25.56 | +1.15 |
Arch Capital F Pref | ACGLO | Nov 18, 2024 | 22.79 | -0.22 |
Arch Capital G | ACGLN | Nov 18, 2024 | 20.07 | +0.15 |
Arch Capital Group | ACGL | Nov 18, 2024 | 96.98 | -4.76 |
Arch Resources A | ARCH | Nov 18, 2024 | 166.27 | +1.30 |
Archer Aviation A | ACHR | Nov 18, 2024 | 4.41 | +7.30 |
Archer Daniels Midland | ADM | Nov 18, 2024 | 52.71 | -1.20 |
Archrock | AROC | Nov 18, 2024 | 23.96 | +3.19 |
Arcos Dorados | ARCO | Nov 18, 2024 | 8.76 | -0.45 |
Arcosa | ACA | Nov 18, 2024 | 103.65 | +2.23 |
Arcturus Therapeutics | ARCT | Nov 18, 2024 | 16.27 | +1.56 |
Arcus Biosciences | RCUS | Nov 18, 2024 | 14.43 | -8.09 |
Arcutis Biotherapeutics | ARQT | Nov 18, 2024 | 9.43 | +1.84 |
Ardagh Metal Packaging | AMBP | Nov 18, 2024 | 3.61 | -0.28 |
Ardelyx | ARDX | Nov 18, 2024 | 4.96 | -0.20 |
Ardent Health Partners | ARDT | Nov 18, 2024 | 17.00 | +2.35 |
Ardmore Shipping | ASC | Nov 18, 2024 | 11.94 | +1.44 |
Ares Acquisition II | AACT | Nov 18, 2024 | 10.89 | +0.09 |
Ares Capital | ARCC | Nov 18, 2024 | 21.68 | +0.79 |
Ares Commercial Real Estate | ACRE | Nov 18, 2024 | 6.98 | +1.16 |
Ares Dynamic Credit Allocation Fund | ARDC | Nov 18, 2024 | 15.18 | +1.07 |
Ares Management A | ARES | Nov 18, 2024 | 167.43 | +0.13 |
Ares Management Pref B | ARES-B | Nov 18, 2024 | 54.00 | 0.00 |
Argan | AGX | Nov 18, 2024 | 139.64 | +2.20 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.